SAN FRANCISCO, January 30, 2017 /PRNewswire/ --
The structural biology & molecular modeling techniques marketis expected to reach USD 13.1 billion by 2025, according to a new study by Grand View Research, Inc. An unprecedented rise in the adoption of unhealthy lifestyles has led to an upsurge in the prevalence of chronic
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.
The heightening demand for molecular modeling techniques is predominantly attributable to the significant cost reduction enabled. This is due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages. Consequentially, the aforementioned factors serve as prominent reasons responsible for the widened market demand.
Browse full research report with TOC on "Structural Biology & Molecular Modeling Techniques Market Analysis By Tools (SaaS & Standalone Modeling, Homology Modeling, Threading, Molecular Dynamics, Ab Initio, Visualization & Analysis, Databases), By Application, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/structural-biology-and-molecular-modeling-technique-market
Further key findings from the study suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the structural biology & molecular modeling techniques market on the basis of tools, applications, and region:
Read Our Blogs - Structural biology & molecular modeling techniques: Advanced technology to aid in drug discovery process
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All